Monday 27 November 2017

Gp96 Peptide Antagonist gp96-II Confers Therapeutic Effects in Murine Intestinal Inflammation

Claudia Nold-Petry et al. published in Frontiers in Immunology.

Read article here.

No comments:

Post a Comment